Literature DB >> 9949426

Role of local amphotericin B therapy for sino-orbital fungal infections.

S R Seiff1, P H Choo, S R Carter.   

Abstract

PURPOSE: Sino-orbital fungal infections are serious complications of diabetes and immunosuppression. Standard treatments include surgical debridement of the involved tissues with possible orbital exenteration, intravenous antifungal therapy, and improvement of the host's immunocompetence and metabolic state, when possible. The role of conservative orbital debridement combined with local amphotericin B irrigations in the treatment of these patients was evaluated.
METHODS: The records of seven consecutive patients with sino-orbital fungal infections, who were treated with limited surgical debridement and local and systemic amphotericin B therapy, were reviewed. The underlying disorders of these patients included acute lymphoblastic leukemia, immunosuppression after renal transplantation, diabetes mellitus, and acquired immunodeficiency syndrome. The fungal species identified included Rhizopus, Mucor, and Aspergillus.
RESULTS: Follow-up ranged from 4 months to 4 years. All patients retained their preoperative visual acuities. Only one patient ultimately underwent an orbital exenteration for progressive orbital fungal infection. The remaining patients had either complete or incomplete (without further progression) resolution of their fungal infection. Two of the seven patients died of unrelated causes, and no patient died of uncontrolled fungal spread.
CONCLUSIONS: Conservative orbital debridement with local amphotericin B irrigations is an effective adjunct in the control of sino-orbital fungal infections, especially in patients with reversible immunosuppression and good preoperative visual acuities.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9949426     DOI: 10.1097/00002341-199901000-00007

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  17 in total

Review 1.  Current perspectives on ophthalmic mycoses.

Authors:  Philip A Thomas
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

2.  Rhinocerebral mucormycosis: A deadly disease on the rise.

Authors:  R S Mane; J K Watve; A A Mohite; B C Patil
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2007-09-14

3.  Lethargy and vision loss: successful management of rhinocerebral mucormycosis.

Authors:  Ramzi Mulki; Muhammad Masab; Glenn Eiger; Sarah Perloff
Journal:  BMJ Case Rep       Date:  2016-06-02

4.  Aggressive Combined Medical and Surgical Management of Mucormycosis Results in Disease Eradication in 2 Pediatric Patients.

Authors:  Haley F M Augustine; Colin White; James Bain
Journal:  Plast Surg (Oakv)       Date:  2017-06-28       Impact factor: 0.947

5.  Invasive Fungal Sinusitis: Risk Factors for Visual Acuity Outcomes and Mortality.

Authors:  Kristin E Hirabayashi; Oluwatobi O Idowu; Evan Kalin-Hajdu; Catherine E Oldenburg; Frank L Brodie; Robert C Kersten; M Reza Vagefi
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2019 Nov/Dec       Impact factor: 2.011

Review 6.  Fungal infections of the orbit.

Authors:  Bipasha Mukherjee; Nirav Dilip Raichura; Md Shahid Alam
Journal:  Indian J Ophthalmol       Date:  2016-05       Impact factor: 1.848

7.  Rhino-orbital Mucormycosis: Clinical Findings and Treatment Outcomes of Four Cases.

Authors:  Şeyda Karadeniz Uğurlu; Sedat Selim; Aylin Kopar; Murat Songu
Journal:  Turk J Ophthalmol       Date:  2015-08-05

8.  Orbital compartment syndrome following retrobulbar injection of amphotericin B for invasive fungal disease.

Authors:  Frank L Brodie; Evan Kalin-Hajdu; Debbie S Kuo; Kristin E Hirabayashi; Reza Vagefi; Robert C Kersten
Journal:  Am J Ophthalmol Case Rep       Date:  2016-02-10

9.  Fungal septal abscess complicating maxillary sinus fungus balls in an immunocompetent host.

Authors:  Rusha Patel; Richard R Orlandi
Journal:  Allergy Rhinol (Providence)       Date:  2015-01

Review 10.  Rare Orbital Infections ~ State of the Art ~ Part II.

Authors:  Shirin Hamed-Azzam; Islam AlHashash; Daniel Briscoe; Geoffrey E Rose; David H Verity
Journal:  J Ophthalmic Vis Res       Date:  2018 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.